They can be broadly classified as exendin-based therapies (exenatide, exenatide once weekly), DPP-4-resistant analogues (lixisenatide, albiglutide), and analogues of human GLP-1 (liraglutide, taspoglutide)
Its a meaningful improvement for overall cardiovascular risk even if the absolute number doesnt shift dramatically
Ask for the specific criterion that was missed, address it, and resubmit
Because the two medications interact with the brain and gut slightly differently, a patient who struggles with one may find the other much easier to manage
This is an 84 year-old-male, who in a period of ten years had three hospitalizations because of enterorrhagia due to a diverticular disease, this time he was admitted for recurrence of the bleeding, the day before had made a previous colonoscopy, which found diverticulosis throughout the entire colon including some diverticulae of the terminal ileum, no finding the exact site of bleeding